No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr4:122680600-122685600 |
Weak transcription |
Osteobl |
bone
|
2 |
chr4:122683800-122685600 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
3 |
chr4:122684800-122685600 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
4 |
chr4:122684800-122686400 |
Active TSS |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
5 |
chr4:122685000-122685600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
6 |
chr4:122685000-122685800 |
Bivalent/Poised TSS |
Brain Inferior Temporal Lobe |
brain
|
7 |
chr4:122685000-122687000 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
8 |
chr4:122685200-122685600 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
9 |
chr4:122685200-122685600 |
Bivalent Enhancer |
HUVEC |
blood vessel
|
10 |
chr4:122685200-122685800 |
Bivalent Enhancer |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
11 |
chr4:122685200-122685800 |
Enhancers |
Spleen |
Spleen
|
12 |
chr4:122685200-122686200 |
Bivalent/Poised TSS |
Duodenum Smooth Muscle |
Duodenum
|
13 |
chr4:122685200-122686400 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
14 |
chr4:122685200-122686600 |
Bivalent/Poised TSS |
H1 Cell Line |
embryonic stem cell
|
15 |
chr4:122685200-122686600 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
16 |
chr4:122685200-122686600 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
17 |
chr4:122685200-122686600 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
18 |
chr4:122685200-122686600 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells |
blood
|
19 |
chr4:122685200-122686600 |
Bivalent/Poised TSS |
Fetal Kidney |
kidney
|
20 |
chr4:122685200-122686800 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
21 |
chr4:122685200-122686800 |
Active TSS |
HSMM |
muscle
|
22 |
chr4:122685200-122686800 |
Active TSS |
NHLF |
lung
|
23 |
chr4:122685400-122685600 |
Bivalent Enhancer |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
24 |
chr4:122685400-122685600 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
25 |
chr4:122685400-122685600 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
26 |
chr4:122685400-122685600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
27 |
chr4:122685400-122685600 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
28 |
chr4:122685400-122685600 |
Bivalent/Poised TSS |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
29 |
chr4:122685400-122685600 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
30 |
chr4:122685400-122685600 |
Bivalent Enhancer |
Fetal Brain Female |
brain
|
31 |
chr4:122685400-122685600 |
Flanking Active TSS |
Fetal Heart |
heart
|
32 |
chr4:122685400-122685600 |
Bivalent/Poised TSS |
Fetal Lung |
lung
|
33 |
chr4:122685400-122685800 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
34 |
chr4:122685400-122685800 |
Bivalent/Poised TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
35 |
chr4:122685400-122685800 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
36 |
chr4:122685400-122685800 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
37 |
chr4:122685400-122686000 |
Flanking Bivalent TSS/Enh |
Fetal Muscle Trunk |
muscle
|
38 |
chr4:122685400-122686000 |
Flanking Bivalent TSS/Enh |
Fetal Muscle Leg |
muscle
|
39 |
chr4:122685400-122686200 |
Active TSS |
Right Ventricle |
heart
|
40 |
chr4:122685400-122686400 |
Bivalent/Poised TSS |
Placenta |
Placenta
|
41 |
chr4:122685400-122686600 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
42 |
chr4:122685400-122687000 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
43 |
chr4:122685400-122687000 |
Bivalent/Poised TSS |
Brain Dorsolateral Prefrontal Cortex |
brain
|